Amgen Cash on Hand 2006-2019 | AMGN

Amgen cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Amgen cash on hand for the quarter ending December 31, 2019 was $8.911B, a 69.59% decline year-over-year.
  • Amgen cash on hand for 2019 was $8.911B, a 69.59% decline from 2018.
  • Amgen cash on hand for 2018 was $29.304B, a 29.69% decline from 2017.
  • Amgen cash on hand for 2017 was $41.678B, a 9.43% increase from 2016.
Amgen Annual Cash on Hand
(Millions of US $)
2019 $8,911
2018 $29,304
2017 $41,678
2016 $38,085
2015 $31,382
2014 $27,026
2013 $19,401
2012 $24,061
2011 $20,641
2010 $17,422
2009 $13,442
2008 $9,552
2007 $7,151
2006 $6,277
2005 $5,255
Amgen Quarterly Cash on Hand
(Millions of US $)
Q4 2019 $8,911
Q3 2019 $20,853
Q2 2019 $21,758
Q1 2019 $26,301
Q4 2018 $29,304
Q3 2018 $29,921
Q2 2018 $29,395
Q1 2018 $32,172
Q4 2017 $41,678
Q3 2017 $41,351
Q2 2017 $39,227
Q1 2017 $38,398
Q4 2016 $38,085
Q3 2016 $37,980
Q2 2016 $35,034
Q1 2016 $34,740
Q4 2015 $31,382
Q3 2015 $31,120
Q2 2015 $29,993
Q1 2015 $27,118
Q4 2014 $27,026
Q3 2014 $28,075
Q2 2014 $26,188
Q1 2014 $19,802
Q4 2013 $19,401
Q3 2013 $22,558
Q2 2013 $22,018
Q1 2013 $21,271
Q4 2012 $24,061
Q3 2012 $25,374
Q2 2012 $22,475
Q1 2012 $19,374
Q4 2011 $20,641
Q3 2011 $17,676
Q2 2011 $19,172
Q1 2011 $15,358
Q4 2010 $17,422
Q3 2010 $17,049
Q2 2010 $14,523
Q1 2010 $14,117
Q4 2009 $13,442
Q3 2009 $14,013
Q2 2009 $11,965
Q1 2009 $10,378
Q4 2008 $9,552
Q3 2008 $9,757
Q2 2008 $8,483
Q1 2008 $8,647
Q4 2007 $7,151
Q3 2007 $5,950
Q2 2007 $5,306
Q1 2007 $4,837
Q4 2006 $6,277
Q3 2006 $5,781
Q2 2006 $4,970
Q1 2006 $7,147
Q4 2005 $5,255
Q3 2005 $5,551
Q2 2005 $4,440
Q1 2005 $4,035
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $131.403B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
CSL (CSLLY) Australia $100.847B 0.00
Gilead Sciences (GILD) United States $88.181B 11.35
Vertex Pharmaceuticals (VRTX) United States $63.855B 57.95
Biogen (BIIB) United States $58.609B 10.01
Regeneron Pharmaceuticals (REGN) United States $44.354B 18.79
Illumina (ILMN) United States $43.503B 44.98
Alexion Pharmaceuticals (ALXN) United States $22.835B 10.62
Seattle Genetics (SGEN) United States $20.154B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.535B 37.62
BioMarin Pharmaceutical (BMRN) United States $17.093B 0.00
Genmab (GNMSF) Denmark $15.432B 49.63
Galapagos (GLPG) Belgium $15.022B 38.71
Alnylam Pharmaceuticals (ALNY) United States $14.752B 0.00
Exact Sciences (EXAS) United States $12.981B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.354B 0.00
Sarepta Therapeutics (SRPT) United States $9.242B 0.00
QIAGEN (QGEN) Netherlands $8.430B 25.96
Guardant Health (GH) United States $8.340B 0.00
Bio-Techne Corp (TECH) United States $7.902B 54.08
BioNTech SE (BNTX) Germany $7.320B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.951B 0.00
Ascendis Pharma (ASND) Denmark $6.774B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.649B 16.91
Exelixis (EXEL) United States $6.408B 18.03
Amarin (AMRN) Ireland $6.405B 0.00
Reata Pharmaceuticals (RETA) United States $6.391B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.140B 0.00
Moderna (MRNA) United States $6.135B 0.00
Repligen (RGEN) United States $5.107B 93.44
Acceleron Pharma (XLRN) United States $5.017B 0.00
China Biologic Products (CBPO) China $4.603B 25.93
Bluebird Bio (BLUE) United States $4.460B 0.00
Adaptive Biotechnologies (ADPT) United States $4.247B 0.00
MorphoSys AG (MOR) Germany $3.917B 0.00
Mirati Therapeutics (MRTX) United States $3.725B 0.00
Blueprint Medicines (BPMC) United States $3.654B 0.00
Immunomedics (IMMU) United States $3.492B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.438B 0.00
Zai Lab (ZLAB) China $3.435B 0.00
Emergent Biosolutions (EBS) United States $3.404B 23.81
NeoGenomics (NEO) United States $3.392B 180.50
Momenta Pharmaceuticals (MNTA) United States $3.347B 0.00
Genmab (GMAB) Denmark $3.247B 12.74
CRISPR Therapeutics AG (CRSP) Switzerland $3.227B 54.67
Halozyme Therapeutics (HALO) United States $3.199B 0.00
Alkermes (ALKS) Ireland $3.194B 253.00
Intercept Pharmaceuticals (ICPT) United States $3.109B 0.00
MyoKardia (MYOK) United States $3.076B 0.00
Insmed (INSM) United States $2.792B 0.00
Amicus Therapeutics (FOLD) United States $2.747B 0.00
UniQure (QURE) Netherlands $2.645B 0.00
Arena Pharmaceuticals (ARNA) United States $2.640B 6.14
Denali Therapeutics (DNLI) United States $2.348B 0.00
Fate Therapeutics (FATE) United States $2.339B 0.00
Epizyme (EPZM) United States $2.266B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Principia Biopharma (PRNB) United States $2.154B 0.00
Alector (ALEC) United States $2.100B 0.00
REGENXBIO (RGNX) United States $1.939B 0.00
Ligand Pharmaceuticals (LGND) United States $1.769B 51.66
Zymeworks (ZYME) Canada $1.758B 0.00
Akcea Therapeutics (AKCA) United States $1.707B 0.00
Arvinas (ARVN) United States $1.703B 0.00
Coherus BioSciences (CHRS) United States $1.580B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Myriad Genetics (MYGN) United States $1.465B 25.85
Zealand Pharma (ZLDPF) Denmark $1.461B 0.00
Zealand Pharma (ZEAL) Denmark $1.459B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.425B 0.00
Intra-Cellular Therapies (ITCI) United States $1.369B 0.00
Editas Medicine (EDIT) United States $1.269B 0.00
Revance Therapeutics (RVNC) United States $1.254B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.194B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.187B 0.00
Twist Bioscience (TWST) United States $1.172B 0.00
Athenex (ATNX) United States $1.142B 0.00
PHARMA MAR SA (PHMMF) Spain $1.024B 0.00
Adverum Biotechnologies (ADVM) United States $0.959B 0.00
Mesoblast (MESO) Australia $0.922B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
DBV Technologies S.A (DBVT) France $0.906B 0.00
Cytokineticsorporated (CYTK) United States $0.903B 0.00
Sangamo Therapeutics (SGMO) United States $0.863B 0.00
Vericel (VCEL) United States $0.859B 320.25
Codexis (CDXS) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.799B 0.00
Arcus Biosciences (RCUS) United States $0.794B 0.00
Heska (HSKA) United States $0.790B 201.94
Intrexon (PGEN) United States $0.769B 0.00
ANI Pharmaceuticals (ANIP) United States $0.743B 12.67
Retrophin (RTRX) United States $0.742B 0.00
Cara Therapeutics (CARA) United States $0.690B 0.00
GENFIT S.A (GNFT) France $0.676B 0.00
Kadmon Holdings (KDMN) United States $0.658B 0.00
Intellia Therapeutics (NTLA) United States $0.655B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.650B 5.47
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.633B 0.00
Anika Therapeutics (ANIK) United States $0.610B 20.85
Clovis Oncology (CLVS) United States $0.603B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.597B 0.00
Bellus Health (BLU) Canada $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.568B 13.14
NantKwest (NK) United States $0.566B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.530B 0.00
Compugen (CGEN) Israel $0.513B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.499B 0.00
BioDelivery Sciences (BDSI) United States $0.498B 0.00
Agenus (AGEN) United States $0.484B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Cue Biopharma (CUE) United States $0.456B 0.00
Merus (MRUS) Netherlands $0.445B 0.00
AnaptysBio (ANAB) United States $0.438B 0.00
Sorrento Therapeutics (SRNE) United States $0.426B 0.00
Mersana Therapeutics (MRSN) United States $0.422B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.421B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.420B 0.00
Dynavax Technologies (DVAX) United States $0.409B 0.00
Precision BioSciences (DTIL) United States $0.407B 0.00
Avid Bioservices (CDMO) United States $0.405B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.397B 9.94
Adaptimmune Therapeutics (ADAP) United Kingdom $0.393B 0.00
Inovio Pharmaceuticals (INO) United States $0.380B 0.00
Gritstone Oncology (GRTS) United States $0.374B 0.00
Stemline Therapeutics (STML) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.332B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.322B 0.00
MannKind (MNKD) United States $0.322B 0.00
Cellular Biomedicine (CBMG) United States $0.322B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.312B 0.00
WAVE Life Sciences (WVE) Singapore $0.305B 0.00
Starpharma Holdings (SPHRY) Australia $0.302B 0.00
OSMOTICA PHARM (OSMT) United States $0.301B 0.00
Aduro Biotech (ADRO) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.286B 1.98
Syndax Pharmaceuticals (SNDX) United States $0.284B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.272B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
Kamada (KMDA) Israel $0.268B 11.17
Seres Therapeutics (MCRB) United States $0.267B 0.00
VBI Vaccines (VBIV) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.266B 0.00
IVERIC Bio (ISEE) United States $0.254B 0.00
Geron (GERN) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
Novavax (NVAX) United States $0.248B 0.00
Protagonist Therapeutics (PTGX) United States $0.246B 0.00
XOMA (XOMA) United States $0.242B 0.00
Prometic Life Sciences (LMNL) Canada $0.241B 0.00
Kala Pharmaceuticals (KALA) United States $0.239B 0.00
ChromaDex (CDXC) United States $0.239B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Alcobra (ARCT) United States $0.226B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
ADMA Biologics Inc (ADMA) United States $0.218B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.217B 0.00
Cerecor (CERC) United States $0.212B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Theratechnologies (THTX) Canada $0.207B 0.00
Affimed (AFMD) Germany $0.206B 0.00
Arbutus Biopharma (ABUS) Canada $0.202B 0.00
TELA Bio (TELA) United States $0.201B 0.00
Athersys (ATHX) United States $0.201B 0.00
Five Prime Therapeutics (FPRX) United States $0.195B 0.00
Fortress Biotech (FBIO) United States $0.192B 0.00
Exicure (XCUR) United States $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.184B 0.00
VTv Therapeutics (VTVT) United States $0.181B 0.00
Strongbridge Biopharma (SBBP) United States $0.177B 4.72
Northwest Biotherapeutics (NWBO) United States $0.171B 0.00
Verastem (VSTM) United States $0.162B 0.00
Selecta Biosciences (SELB) United States $0.159B 0.00
Aptinyx (APTX) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Windtree Therapeutics (WINT) United States $0.156B 0.00
Dyadic (DYAI) United States $0.149B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.144B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
ARAVIVE, INC (ARAV) United States $0.131B 0.00
Arsanis (XFOR) United States $0.130B 0.00
Menlo Therapeutics (MNLO) United States $0.127B 0.00
OvaScience (MLND) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.118B 0.00
Clearside Biomedical (CLSD) United States $0.118B 0.00
Prima BioMed (IMMP) Australia $0.110B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
Proteostasis Therapeutics (PTI) United States $0.102B 0.00
Happiness Biotech Group (HAPP) China $0.101B 0.00
Applied Genetic Technologies (AGTC) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.092B 0.00
Synlogic (SYBX) United States $0.091B 0.00
Checkpoint Therapeutics (CKPT) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.086B 0.00
Pluristem Therapeutics (PSTI) Israel $0.080B 0.00
Orgenesis (ORGS) United States $0.074B 4.74
Acorda Therapeutics (ACOR) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Trevena (TRVN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Soligenix (SNGX) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Advaxis (ADXS) United States $0.059B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Idera Pharmaceuticals (IDRA) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
TOCAGEN INC (TOCA) United States $0.045B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Entera Bio (ENTX) Israel $0.037B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Celsion (CLSN) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
VIVUS (VVUS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.004B 0.00